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SIMON, A.B., AND ZLOTO, A.E. Symptomatic sinus node disease: Natural history
after permanent ventricular pacing. Fifty-nine patients between the ages of 13 and
88 with sinus node disease, who received a permanent ventricular pacemaker be-
tween 1965 and 1976 at one institution, were followed to determine the natural
history of the disorder after permanent pacing. Nineteen had ischemic heart dis-
ease, six had primary myocardiaJ disease, and eight vaJvuJar heart disease. In 26, no
etiology for the arrhythmia was apparent. The one- and five-year survival was
85,5% and 73,1%, respectively. Patients with underlying heart disease had a signifi-
cantly poorer survival when compared to those without (58% versus 94% at 36
months], and all but 3 of 13 deaths in the first 36 months were in those with isch-
emic heart disease. There was a distinct trend toward poor survival in those with
heart failure prior to pacemaker implant and those over age 65, Patients with sinus
bradycardia alone did best (91% survival three years after implantj, while those
with bradycardia-tachycardia syndrome and those with sinoatrial arrest alone did
distinctly worse f76% and 65% survival at three years, respectively}. Twelve of 18
deaths were due to progression of underlying heart disease. The long-term prog-
nosis with symptomatic sinus node disease can be predicted in part by (lj etiology
of the underlying heart disease, [2} pre-implant arrhythmia, and (3J ventricular
function prior to implant. (PACE, Vol. 2, May-June, 1979]
bradycardia-tachycardia syndrome, patient longevity
Sinus node disease is manifested by either in-
termittent or persistent severe sinus brady-
cardia, sinoatrial block or periods of sinoatrial
arrest,'"' In its symptomatic stage, patients may
have pre-syncope or syncope palpitations due to
supraventricular tachyarrhythmias or conges-
tive heart failure.*'̂  Sinus node disease may be
associated with congenital, valvular, myo-
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pathic, or ischemic heart disease, but many pa-
tients have no apparent etiology,*'' The course
of untreated symptomatic sinus node disease is
unknown, because permanent pacing was used
for symptom palliation prior to the availability
of natural history studies. Frequently, pacing
must be combined with treatment of congestive
failure or tachyarrhythmias for maximium pal-
liation of symptoms."'' This report describes the
natural history of symptomatic patients with
sinus node disease who have received a ven-
tricular pacemaker at one institution, and
elucidates factors which correlate with late
mortality and morbidity.




All adult patients who received their initial
permanent pacemaker implantation for symp-
tomatic sinus node disease at the University of
Michigan Medical Center between July 1, 1965
and June 30, 1978 constitute the subjects of this
report. Six patients with both sinus node dys-
function and atrioventricular block were ex-
cluded from this analysis and are described else-
where.' Seven patients who had previously
received their initial pacemaker elsewhere for
this Indication but were subsequently followed
here were also excluded. All patients were
paced from the ventricle. The diagnosis of sinus
node disease was made on clinical and electro-
cardiographic grounds''"'' and corroborated by
electrophysiologic testing in some. The diag-
nosis for inclusion in this study in the patients
paced prior to the description of the syndrome'
was made retrospectively during a systematic
evaluation of all patients receiving a perman-
ent pacemaker in this institution.' Selected
variables from the history, clinical course, se-
quential electrocardiograms, including Holter
monitoring before and after pacemaker inser-
tion, and follow-up information were trans-
ferred to computer tape and analyzed using
methods previously described." All patients
were assessed systematically at intervals no
longer than six months. Special attention was
paid to the atriai and underlying ventricular es-
cape mechanism with pacemaker inhibition or
at the time of pulse generator replacement. Sur-
vival curves were calculated according to the
life table method using the Michigan Interac-
tive Data Analysis System (MIDAS)" and the In-
teractive Graphic Survival Analysis System
(IGSAS).'° Survival time for each patient ex-
tended from the date of initial pacemaker im-
plant until death or June 30,1978. The Breslow's
generalized Kruskal-Wallis Test was utilized to
determine if the survival distribution differed
across strata for any single pre-implant
variable."
The etiology of the underlying heart disease
and arrhythmias complex in each patient was
classified according to clinical data at the time
of initial pacemaker implant. Arteriosclerotic
heart disease was accepted as etiologic only if
the patient had a past history of definite angina
pectoris, or ECG or enzyme evidence of prior
myocardial infarction. Valvular heart disease or
primary cardiomyopathy was diagnosed ac-
cording to recognized clinical and catheteriza-
tion critieria. Patients without apparent under-
lying cardiac disease were classified as 'idio-
pathic'. The method for the determination of the
cause of death was similar to that previously
described."'" When more than one etiology of
heart disease was identified classification was
according to the clinically dominant type at
entry. Details concerning the circumstances of
death were obtained by interview of physician,
family member, or other informed witnesses.
Sudden death was defined as death within one
hour after the onset of symptoms. Congestive
heart failure was diagnosed utilizing the criteria
of McKee.'̂  Chronic atriai fibrillation was
defined as the presence of this arrhythmia on
three successive electrocardiograms at least one
year apart. During the time of the study, pa-
tients were paced from the ventricle at rates be-
tween 68 and 72 beats/minute with either
General Electric,* Medtronic,** CPI*** or Cor-
pacing systems.
Results
Between 1965 and 1978, 59 adult patients re-
ceived their initial permanent pacemaker for
treatment of sinus node disease at the Univer-
sity of Michigan. Only 10 had their initial im-
plant prior to 1970. Although representing only
16% of all patients who have received perman-
ent pacemakers at this institution since 1961,
this has been the indication for pacing for 30%
of all patients who received their initial unit
since 1972. The mean follow-up period was 50
months (range; 1-120 monthsj. One patient has
been lost to follow-up. There were 33 men and
26 women. They ranged in age from 13 to 88. The
*General Electric,
**Medtronic, Inc., Minneapolis, Minn., U.S.A.
***Cardiac Pacemakers, Inc., St. Paul, Minn., U.S.A.
:j:Cordis Corp., Miami, Florida, U.S.A.
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Tabie 1.
Correlation Between Clinically Apparent Etiology of the Patients' Heart Disease and Selected Clinical









































































COPD = Chronic obstructive pulmonary disease
mean age at initial implant was 64.6 years.
Thirty-eight were over age 65. The clinical
features of the entire group are summarized in
Table I. There were 19 patients with ischemic
heart disease, of whom three also had hyper-
tensive heart disease and four mitral insuffi-
ciency attributed to papillary muscle dysfunc-
tion. Six patients had primary myocardial dis-
ease, and eight had valvular disease. One of
these has mitral valve prolapse with long QT
syndrome, one isolated aortic stenosis, five
rheumatic valve disease, and one patient has a
tricuspid valve replacement secondary to endo-
carditis. Twenty-six patients had no apparent
cardiac disease except the arrhythmia. Two pa-
tients in this latter group had quadriplegia or
hemiplegia from spinal cord trauma.
diabetes mellitus, 14 had systolic ( > 160 mm Hg)
and 11 diastolic ( > 95 mm Hg) hypertension (as
determined on at least two blood pressure de-
terminations); obesity was present in 22,
chronic obstructive pulmonary disease in eight,
and renal insufficiency in 13; six of the 36 men
had obstructive uropathy; five patients had a
past history of malignant neoplasm. The pre-
valence rate of diabetes mellitus far exceeds
that in the general population,'^ and is higher
than in patients with atrioventricular block pre-
viously reported from this institution.' Five pa-
tients had a definite stroke prior to pacemaker
implant. Two patients had carotid bruits.
Organic brain syndrome, Parkinson's disease
and previous saddle embolus were diagnosed in
single patients.
Previous Status
Coexistent Disease Before Implant
There was a high prevalence of chronic dis-
eases in this population. Twenty-four Had
Cardiac Status Before Implant
Sinus bradycardia alone, either in combina-
tion with congestive failure incompletely re-
sponsive to medical therapy (five patients) or
with syncope historically without dpcumenta-
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Table II.
































tion of sinoatrial block (five patients), was seen
in ten. Characteristically, rates under 50/min
were seen and, in most cases, rates failed to ex-
ceed 70/min with moderate exercise. Sinoatrial
block or arrgst" in combination with sinus
bradycardia was seen in 30 patients; 19 patients
were classified as having "bradycardia-tachy-
cardia syndrome". Twelve of these had atrial fi-
brillation or flutter, two had multifocal atrial
tachycardia and five had atrial tachycardia.
There was no correlation between the etiology
of heart disease and the type of arrhythmia seen
(Table II).
Ventricular premature beats were also com-
mon. Twelve patients had unifocal, and two had
multifocal PVCs during their pre-implant
evaluation; seven patierits had one or more
episodes of ventricular tachycardia, and one pa-
tient had been resuscitated from ventricular fi-
brillation prior to pacemaker implant. Left bun-
dle branch block was present in four, isolated
right bundle branch block in two, left anterior
fascicular block in two, right bundle branch
block with left anterior fascicular block in
three, alternating right and left bundle branch
block in one, and prolonged PR interval in 15.
Sixteen patients had congestive heart failure
in combination with their arrhythmia. Eleven
patients had mild, and eleven had marked
cardiomegaly by chest roentgenogram. There
was a wide variability in the duration of sympr
toms among all patients, regardless of etiology
of heart disease. Twenty-four patients had
symptoms of heart disease or arrhythmias for
less than one year, but 18 patients had symp-
toms for over five years. The median duration of
symptoms for patients in the idiopathic group
was 12 months (range: < 1 month - 18 years),
while those with ischemic heart disease had a
median duration of symptoms of 54 months.
Forty-six of the 59 patients had presyncope or
syncope; 23 described these symptoms for over
12 months; nine of these had described such epi-
sodes for eight years or more.
Course Following Pacemaker Implant
Mortality
Overall survival and the correlation between
survival and underlying cardiac disease is
shown in Figure 1. Eighteen patients have died
in the follow-up period. The six-month, one-
year and five-year survival was 91%, 85.5%, and
73.1%, respectively. Early deaths were usually
cardiac, while late deaths were usually due to
non-cardiac causes. Mortality was significantly
higher in those with ischemic heart disease (p <
0.02) (Fig. 1), and tended to be higher in those
with congestive heart failure prior to implant (p
= 0.07). Mortality was very low in those with
sinus bradycardia alone (85.9% survival at three
years), but significantly greater in those with
sinoatrial arrest or bradycardia-tachycardia
syndrome (64.8% and 75.6%, respecti,vely) (p<
.05) (Fig. 2). There was a poorer correlation be-
308 May-June 1979 PACE, Vol. 2





•» • • ALL PATIENTS
(n-99)
1 2 3 4 5
YEARS
Figure 1. Correlation between survival and eti-
ology of underlying cardiac ciisease io 60 months of
follow-up using the life tahle method. Five patients,
two with cardiomyopathy, one with rheumatic heart
disease, and two with no cardiac disease, died 61 to
96 months post-impJant and are not presented on the
survival curves. Numbers in parenthesis indicate
numbers of patients at risk at each interval.
tween survival and age. The five-year survival
for those less than 65 years old was 74%, and
637o for those over 65 (N,S,, p = 0.17), The mor-
tality exceeded that of sex- and age-matched
cohtrols from the general U,S, population.'
Progressive and refractory congestive heart
failure was a common cause of death; three of
18 deaths in this series were primarily at-
tributed to heart failure (Table III), Six addi-
tional patients died of definite (unequivocal
ECG, enzyme or autopsy data) or probable
(characteristic history but no autopsy confirma-
tion) acute myocardial infarction. Two patients
with ischemic heart disease died of an acute
myocardial infarction and shock within five
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Figure 2. Correlation between survival and ar-
rhythmia prior to implant. Four patients with sino-
atrial arrest and one patient with bradycardia-tachy-
cardia syndrome died 61 to 96 months post-implant
and are not presented on, the survival curves.
Numbers in parenthesis indicate numbers of pa-
tients at risk at each interval.
implantation. Three patients died suddenly, two
of whom had ventricular tachycardia before
implant. Therefore, at least 12 of the 18 deaths
were due to cardiac events. In three patients, in-
sufficient data was available to determine the
immediate cause of death, and two patients died
of pulmonary causes. Nine deaths occurred in
the hospital and three in convalescent facili-
ties; eight patients were autopsied. In no pa-
tient did pacemaker malfunction contribute to
death.
Morbidity
Although one of the recognized indications
for permanent pacemaker implantation is to
improve symptoms of congestive failure in pa-
tients with slow heart rates, it was necessary to
continue digitalis or diuretics during follow-up
in all but one patient with heart failure before
implant. However, symptoms generally
improved and overall management was simpli-
fied in most after pacing; five additional pa-
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Tabi« iii.
Correlation Between Primary Cause of Death and Underlying Etiology of Heart Disease as Determined at the

















































*Percent Is expressed as the percent mortaiity in each etiologic subgroup.
tiehts have required treatment for chronic con-
gestive heart failure following pacemaker im-
plantation; in at least three this appeared fol-
lowing a definite or probable myocardial in-
farction. One patient with mitral valve pro-
lapse, sinus bradycardia, long QT syndrome,
and v.entricular tachycardia has been resus-
citated from ventricular fibrillation.
In addition tb the major central nervous
system events before implant, during follow-up
two patients have had a complete stroke and
three have had transient ischemic attacks; jDro-
gressive chronic brain syndrome occurred in
two. Progressive and severe renal insufficiency
was seen in three, and four patients have had
major pulmonary complications (either pul-
monary insufficiency or pulmonary embolus)
which resulted in death in two of these. One pa-
tient has had a new malignancy.
Arrhythmias in the Late FoJJow-up Period
In addition to the resuscitated patient, 16 of
the patients have had elective 24-hour ambula-
tory monitoring on a random basis 1 to 108
months following initial pacemaker implant.
Only two had no PVCs; eight had < 1 PVC/1000
normal or paced beats, but four (25%) had 1 to
10 PCVs and three (18%) have > 30 PVCs/lOOO
normal beats. Ten of the 14 patients with PVCs
have multiformed PVCs, and three have
couplets; two have had sustained ventricular
tachycardia noted during routine monitoring,
which has resulted in the addition of anti-
arrhythmic agents to their present drug
program. Both of these latter patients are in the
cardiomyopathy group. There was no correla-
tion between the severity of the ventricular ar-
rhythmias noted and the etiology of the underly-
ing heart disease.
In two patients in this series, pacing was dis-
continued one and one-half and four years after
implant without return of symptoms. One of the
patients with bradycardia-tachycardia syn-
drome refused pacemaker replacement. Four
years later, he was asymptoitiatic despite the
fact that his pacemaker had ceased functioning.
Mild sinus bradycardia persists. Pacing was
cautiously discontinued 18 months following
implant in a young woman with spinal cord
trauma and sinoatrial block whose initial pace-
maker required removal because of pulse gen-
erator erosion. Her bradyarrhythmia has not
returned.
The long term follow-up of the pattern of
supraventricular arrhythmias is summarized in
Table IV. Seven of the 19 patients (37%) with
bradycardia-tachycardia syndrome have con-
verted to chronic atrial fibrillation during
follow-up. Conversion occurred from 11 to 60
months after implant (mean: 38.6 months). No
patient with isolated sinus bradycardia or sino-
atrial arrest has developed chronic or recur-
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Tabie iV.
Correlation Between Mechanism of Supraventricuiar Arrhythmia Seen Pre-impiant and Supraventricular






































rent supraventricular arrhythmias during
follow-up although the one patient with sinus
bradycardia, mitral valve prolapse, and long QT
syndrome has exercise-induced atrial fibrilla-
tion and atrial tachycardia, and two patients
with sinoatrial arrest have had isolated epi-
sodes of atrial fibrillation. In two patients
(3.8%), high grade AV block was documented at
the time of pacemaker inhibition in the clinic
within one year of initial implant.
Discussion
There is a wide variation in the reported mor-
tality in patients with sinus node disease. In the
series by Rokseth and Hatle,'^ Rubenstein et al,'
Conde et al,= and Aroesty et al,'« death was
reported to be infrequent following pacemaker
implant. Krishaswami and Geraci," and Wohl et
al,'° however, have observed a significant mor-
tality, especially within the first two years after
pacemaker insertion, and similar results are
seen in this study. In part, the reported differ-
ences in survival can be attributed to differ-
ences in patients selection. Conde et al,= for ex-
ample, excluded all patients who had had an
acute myocardial infarction within one year.
Such patients had a poor prognosis in the pres-
ent series. Others have included patients only in
the bradycardia-tachycardia subgroup of this
syndrome.'*'^'"'" Wohl et al" excluded those lost
to follow-up, and Wan et aP° and Rubenstein et
aP included many asymptomatic patients not
permanently paced. The age group from which
the patients are drawn may also play some role.
The age of the group is slightly older than that
reported by Radford and Julian,' but younger
than others.^
It is quite clear from this series that signifi-
cant mortality exists in this population, but that
mortality, particularly early mortality, is highest
in the ischemic heart disease subgroup. For ex-
ample, six of the 19 patients with ischemic heart
disease died within the first 12 months after
pacemaker implant, while only two deaths oc-
curred in the remaining 40 patients without
ischemic heart disease. It should be noted, how-
ever, that those in the ischemic heart disease
subgroup were also slightly older than the pa-
tients with idiopathic, valvular, or primary myo-
cardial disease, and had a higher prevalence of
diabetes mellitus, hypertension, chronic lung
disease, and congestive heart failure. While
none of these factors alone could be demon-
strated to influence mortality in a statistically
significant way in this small study group, their
combined influence may have contributed to
overall mortality. The pattern of mortality was
similar to that reported by Fruehan et al.''
Persistent ventricular arrhythmias during
follow-up were common, but their presence did
not appear to correlate with underlying cardiac
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disease. Of particular interest was the high rate
of conversion of patients with symptomatic
supraventricular arrhythmias prior to implant
to chronic atriai fibrillation during the follow-
up period. In fact, no patient with only sinus
bradycardia or periods of sinoatrial arrest with-
out supraventricular arrhythmias has pro-
gressed to chronic atriai fibrillation during
follow-up, although two have bad transient
atriai fibrillation. Amikam and Riss" reported
tbat seven of 25 patients with sick sinus syn-
drome developed cbronic atriai fibrillation, but
tbis was noted in botb tbe bradyarrbythmia and
tbe bradycardia-tacbycardia subgroups. Vera et
al" bave previously reported tbat 11 of 40 pa-
tients in theiriseries bad done likewise.lt is ap-
parent tbat tbe development of cbronic atriai fi-
brillation is a common late development in pa-
tients witb sinus node disease. It is uncertain
wbetber patients in tbis subgroup will remain in
atriai fibrillation indefinitely or require pacing
at all at tbis time; in no sucb patient in tbis
series bas pacing been discontinued.
Pacing bas been discontinued indefinitely,
bowever, in two patients wben tbe opportunity
arose to re-evaluate tbem witbout a permanent
pacemaker—once because of lack of patient co-
operation in follow-up, and once because late
infection dictated removal of tbe system and a
period of observation. Sucb opportunities are
uncommon, and periodic reassessment of tbe
remaining patients in tbis series at tbe time of
pacemaker inbibition in tbe clinic setting or at
tbe time of pulse generator replacement would
indicate tbat otber tban tbose wbo bave con-
verted to atriai fibrillation, tbere are few wbo
would be likely to bave bad resolution of tbe
bradyarrbytbmia.
Tbe patient witb marked sinus bradycardia
alone represents a difficult problem. Wben
overt syncope bistorically accompanies tbe
bradyarrbythmia, repeated ambulatory moni-
toring or electropbysiologic provocative studies
may elucidate a possible mecbanism for tbe
syncope. Despite tbese efforts, five of tbe ten
patients in tbis series witb sinus bradycardia
alone and syncope bad no sustained asystolic
event documented. Four bave bad resolution of
syncopal episodes. One bas persistent ventricu-
lar arrbytbmias requiring supression. Tbe otber
five bad overt congestive beart failure or severe
activity restriction and sinus bradycardia. One
died suddenly shortly following implant. One is
essentially asymptomatic, altbougb tbe need for
occasional diuretics and pronounced cardio-
megaly persists. Tbe remaining tbree require
continuous treatment for beart failure wbicb is
markedly improved since implant. It is obvious
tbat tbis is not a bomogeneous group of pa-
tients, but in all, management was simplified
and symptoms improved following pacemaker
implant.
Altbougb intraventricular conduction distur-
bances are common prior to implant," in only
two patients bas atrioventricular block been
noted during follow-up. One of tbese bad a pro-
longed PR interval prior to implant. Previous
studies bave indicated tbat progression to atrio-
ventricular block was uncommon in patients
witb sinus node disease paced from tbe coro-
nary sinus. Moss et al" reported tbat only one of
27 patients paced for sinus node disease
developed atrioventricular block during fol-
low-up, and tbis series is in agreement witb tbat
observation. Atriai or coronary sinus pacing,
therefore, would appear to be a logical, and pos-
sibly beneficial, metbod of long-term pacing for
tbe group of patients witb congestive beart fail-
ure in combination witb sinus bradycardia or
sinoatrial arrest. Tbere appears to be only a sm-
all probability tbat conversion to atrioventricu-
lar sequential or ventricular pacing would be
required later in tbeir course.
Tbe survival after pacemaker insertion for
sinus node disease is similar to tbe survival of
patients paced for atrioventricular block
previously reported from tbis institution during
tbe same time period.' From tbis retrospective
analysis of patients witb sinus node disease, tbe
presence of iscbemic beart disease identifies a
patient witb a poor prognosis. A more favor-
able, but bardly benign long-term outlook, exists
for tbe symptomatic group witb beart disease of
anotber etiology.
Progression of ventricular dysfunction, wor-
sening underlying ventricular arrbytbmias lead-
ing to sudden deatb, and a significant risk of
cerebral emboli also appear common in tbis pa-
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tient population and contribute to morbidity
and mortality.^' The result of this analysis sug-
gests that long-term survival following pace-
maker implantation in patients with symp-
tomatic sinus node disease is correlated with a
number of variables, including (1] the etiology
of the underlying heart disease, (2) associated
congestive heart failure, (3) age, and (4) the
specific arrhythmias demonstrated prior to
implant.
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